Brief: Heidelberg Pharma Receives Milestone Payment From Partner Magenta
Sept 14 (Reuters) - HEIDELBERG PHARMA AG HPHA.DE :
* RECEIVES MILESTONE PAYMENT FROM PARTNER MAGENTA
* HAS RECEIVED MILESTONE PAYMENT FROM ITS COOPERATION
PARTNER
MAGENTA THERAPEUTICS, ASSOCIATED WITH INITIATION OF GLP
TOXICOLOGY STUDY FOR DEVELOPMENT CANDIDATE MGTA-117
Source text for Eikon: ID:nEQ2q2ZPga
Further company coverage: HPHA.DE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;;))
Recent news on Heidelberg Pharma AG
See all newsBrief: Heidelberg Pharma And Huadong Medicine Receive Nmpa Approval For Hdp-101 Trial In China
Germany's Heidelberg Pharma H1 sales revenue surges, driven by milestone payments
Brief: Heidelberg Pharma Says Co. And Healthcare Royalty Announce Amendment To Existing Royalty Agreement
Brief: Redhill Biopharma Secures Allowance Of Key Chinese Patent Application For Proprietary COVID-19 Treatment, RHB-107
Brief: Heidelberg Pharma Amends Royalty Financing With Healthcare Royalty